University of Kentucky Markey Cancer Center researchers have identified a cellular pathway that fuels the progression of aggressive, drug-resistant prostate cancer. The findings of the study, ...

Prostate cancer (PCa) is one of the most common malignant tumors in men worldwide. While early detection has improved patient outcomes, effective therapies for advanced disease remain limited.

The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 gozetotide in PSMA-PET scans. The Food and Drug Administration (FDA) has approved ...

It is not unusual for a man of Biden’s age to skip prostate cancer screening, for a variety of reasons. Former president Joe Biden’s newly diagnosed prostate cancer, an aggressive form that has spread ...